Daily summaries

Big-money moves in the US on 24/09/17 (Tue)

Insider buys
147 trades
Insider sales
456 trades
Congress trades
0 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

  • James N. Topper

    BuyMBX Biosciences

    $10M

    Filed 24/09/17

  • Frazier Life Sciences X

    BuyMBX Biosciences

    $10M

    Filed 24/09/17

  • Fhmls X

    BuyMBX Biosciences

    $10M

    Filed 24/09/17

  • Fhmls X

    BuyMBX Biosciences

    $10M

    Filed 24/09/17

  • Forest Baskett

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Ali Behbahani

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Carmen Chang

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Anthony A. Florence Jr.

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Mohamad Makhzoumi

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Paul Edward Walker

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Rick Yang

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Scott D. Sandell

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • NEA Partners 17

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Nea 17 GP

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • New Enterprise Associates 17

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Fairmount Healthcare Fund II

    BuyViridian Therapeutics, Inc.\DE

    $30M

    Filed 24/09/17

  • Fairmount Funds Management

    BuyViridian Therapeutics, Inc.\DE

    $30M

    Filed 24/09/17

  • Fairmount Healthcare Fund II GP

    BuyViridian Therapeutics, Inc.\DE

    $30M

    Filed 24/09/17

  • $2.2M

    Filed 24/09/17

  • $2.2M

    Filed 24/09/17

  • Engaged Capital

    BuyBRC

    $2.2M

    Filed 24/09/17

  • Tiba Aynechi

    BuyMBX Biosciences

    $12M

    Filed 24/09/17

  • Patrick J. Heron

    BuyMBX Biosciences

    $10M

    Filed 24/09/17

  • Edward T. Mathers

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Orbimed Advisors

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • OrbiMed Genesis GP

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • OrbiMed Capital GP VII

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Carl L. Gordon

    BuyMBX Biosciences

    $8M

    Filed 24/09/17

  • Deerfield Private Design Fund V

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • James E. Flynn

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Mgmt

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Mgmt V

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Management Company

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Private Design Fund V

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Mgmt

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • James E. Flynn

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Partners

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Partners

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Management Company

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Deerfield Mgmt V

    BuyBicara Therapeutics

    $630K

    Filed 24/09/17

  • Peter Evan Harwin

    BuyZenas BioPharma

    $5.1M

    Filed 24/09/17

  • Fairmount Funds Management

    BuyZenas BioPharma

    $5.1M

    Filed 24/09/17

  • Fairmount Healthcare Fund II

    BuyZenas BioPharma

    $5.1M

    Filed 24/09/17

  • Tomas Kiselak

    BuyZenas BioPharma

    $5.1M

    Filed 24/09/17

  • OrbiMed Capital GP VII

    BuyMBX Biosciences

    $4M

    Filed 24/09/17

  • Orbimed Advisors

    BuyMBX Biosciences

    $4M

    Filed 24/09/17

  • OrbiMed Genesis GP

    BuyMBX Biosciences

    $4M

    Filed 24/09/17

  • Carl L. Gordon

    BuyMBX Biosciences

    $4M

    Filed 24/09/17

  • Colin T. Moran

    BuyAppian

    $359.5K

    Filed 24/09/17

  • Abdiel Partners

    BuyAppian

    $359.5K

    Filed 24/09/17

US Congress and insider trades on 24/09/17 | Whalegun